P Fabrigli
Overview
Explore the profile of P Fabrigli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
31
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bost V, Chavarin P, Boussoulade F, Fabrigli P, Chabre C, Benamara H, et al.
Vox Sang
. 2015 Jun;
109(4):414-6.
PMID: 26031441
Amotosalen-HCl-UVA (AI) is a process to inactivate pathogens in therapeutic plasma (FFP). Tolerance is the main residual issue in FFP transfusion, and only large series observations are powered enough to...
2.
Garraud O, Chavarin P, Boussoulade F, Morata P, Rochette-Eribon S, Acquart S, et al.
Transfus Clin Biol
. 2014 Feb;
21(1):31-6.
PMID: 24560485
In France, three varieties of therapeutic plasma are being processed, distributed and delivered, currently; however, many more varieties are in use worldwide, which go by the property of labile blood...
3.
Bost V, Odent-Malaure H, Chavarin P, Benamara H, Fabrigli P, Garraud O
Vox Sang
. 2013 Jan;
104(4):337-41.
PMID: 23294315
Background And Objectives: Our objective was to compare the frequency of adverse events (AEs) due to any of the 4 types of fresh-frozen plasma (FFP) prepared and delivered by the...
4.
Navarro C, Ducher E, Tas H, Chabre C, Demeocq F, Fabrigli P, et al.
Arch Pediatr
. 2011 Oct;
18(11):1154-61.
PMID: 21996566
Objectives: This study aimed to describe the professional practices in pediatric transfusion to assess the accuracy of transfusion guidelines in children. Methods: The study retrospectively analyzed the characteristics of all...
5.
Chavarin P, DePutter C, Boussoulade F, Acquart S, Vidal M, Argaud C, et al.
Transfus Clin Biol
. 2011 Jul;
18(4):472-7.
PMID: 21783400
In the past few years, pathogen reduction technologies for labile blood products have been part of the enhancement of global transfusion safety regarding residual risks of transmitting infectious pathogens. Having...
6.
Besiers C, Chavarin P, Fabrigli P, Benamara H, Rochette S, Gras A, et al.
Transfus Clin Biol
. 2011 Jan;
18(1):20-5.
PMID: 21237687
Purpose Of The Study: Like every actor in transfusion, staff members practising within blood banks of healthcare establishments have to follow a specific initial training and must frequently update their...
7.
Ozier Y, Renaudier P, Caldani C, Aguilon P, Canivet N, Fabrigli P, et al.
Transfus Clin Biol
. 2010 Nov;
17(5-6):284-90.
PMID: 21051260
Pulmonary oedema after transfusion of blood products may be hydrostatic (transfusion-associated circulatory overload [taco]) or exsudative (transfusion-related acute lung injury [trali]). Both conditions have been recognized as major hazards to...
8.
Courbil R, Romaszko J, Odent-Malaure H, Fabrigli P, Chavarin P, Tournilhac O, et al.
Transfus Clin Biol
. 2010 Jan;
17(1):9-13.
PMID: 20106699
We recently observed a near fatal case of transfusion-transmitted infection with standard platelet concentrate. Streptococcus dysgalactiae subspecies equisimilis was isolated both from donor, residual component container and cultures of the...
9.
Bay J, Tournilhac O, Ducher E, Romaszko J, Ergani A, Bouvet A, et al.
Vox Sang
. 2009 Jun;
96(3):271.
PMID: 19522886
No abstract available.
10.
Courbil R, Fabrigli P, Garraud O
Transfus Clin Biol
. 2009 May;
16(2):201-3.
PMID: 19442555
In this article, we present transfusion counseling; its organization, actors, their formations and we deal with factual positions. Transfusion counseling needs better identification, tending to a homogeneous organization between every...